Home » Topics » Disease categories and therapies » Endocrine/metabolic

Endocrine/metabolic
RSS

Pharmacia & Upjohn licenses rights to novel JT diabetes drug

June 24, 1998

Controlled study refutes evidence indicating that garlic lowers lipids

June 23, 1998

Lilly expands women's health pipeline

June 23, 1998

Hemosol awarded grant for Hemolink development

June 23, 1998

Symphar, SmithKline Beecham collaborate in the discovery of Lp(a)-lowering agents

June 22, 1998

Orlistat reaches first market

June 19, 1998

Sibutramine: preclinical effects on glucose homeostasis and uptake

June 19, 1998

EXO-226 effective against diabetic nephropathy in db/db mice

June 19, 1998

MD-700, a new LDL receptor-upregulating compound from Taisho

June 19, 1998

Hoe-901: new long-acting insulin for IDDM and NIDDM

June 19, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 6, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
Cytospire raises £61M series A to target EGFR in solid tumors
BioWorld
Next-generation T-cell engager (TCE) specialist Cytospire Therapeutics Ltd. has raised £61 million (US$82.7 million) in a series A round, equipping it to advance...
Bio Korea 2026: US policy risks shift to execution framework
BioWorld
Regulatory uncertainty that dominated the life science sector in 2025 is transitioning into an execution framework for biotechnology companies, provided companies...
Regulatory actions for May 5, 2026
BioWorld
Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Adma, Applied...